Clinical Trial Update: Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of BOL-303242-X Ophthalmic Suspension for dry eye syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• BOL-303242-X Ophthalmic Suspension

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-09-03